Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 52,874	$ 2,813
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	79,463	93,128
Deferred income tax provision (benefit)	(1,130)	603
Net loss (gain) on sales of property and equipment	65	(2,401)
Noncash compensation	9,239	7,413
Other Noncash Income (Expense)	942	(64)
Increase (Decrease) in Accounts Receivable	(135,237)	(130,023)
Excluding the effects of acquisitions, increase (decrease) in cash from:
Inventory	(23,825)	(14,079)
Proceeds from Sale of Debt Securities, Available-for-sale	6,229	0
Other operating assets	(2,841)	4,522
Currency translation effect on working capital, excluding cash	(1,225)	(4,690)
Current liabilities	61,015	14,562
Increase (Decrease) in Other Noncurrent Liabilities	17,800	(10,367)
Total adjustments to net income (loss)	4,266	(41,396)
Net Cash Provided by (Used in) Operating Activities	57,140	(38,583)
Cash Flows from Investing Activities:
Proceeds from Sale of Debt Securities, Available-for-sale	6,229	0
Purchases of property and equipment	(66,681)	(55,094)
Distributions of capital from unconsolidated affiliates	2,520	540
Dispositions of property and equipment	13	6,422
Payments for (Proceeds from) Other Investing Activities	1,346	(3,000)
Net Cash Provided by (Used in) Investing Activities	(56,573)	(51,132)
Cash Flows from Financing Activities:
Other financing activities	(5,136)	(1,862)
Net Cash Provided by (Used in) Financing Activities	(5,136)	(1,862)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(7,749)	(19,030)
Net Increase (Decrease) in Cash and Cash Equivalents	(12,318)	(110,607)
Cash and Cash Equivalents—Beginning of Period	568,745	538,114
Cash and Cash Equivalents—End of Period	$ 556,427	$ 427,507